Cancer vaccines: What do we need to measure in clinical trials?

被引：8
|
作者：
Kudrin, Alex [1 ]
机构：
[1] Celltrion Inc, Inchon, South Korea
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2014年 / 10卷 / 11期
关键词：
cancer vaccines; endpoints; immune response; patient reported outcomes; progression free survival; SIPULEUCEL-T; IMMUNOTHERAPY; SURVIVAL; APPROVAL; THERAPY;
D O I：
10.4161/hv.27586
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Cancer immunotherapy has seen a tremendous number of failures and only few recent regulatory successes. This review is dedicated to evaluate remaining challenges in capturing clinical response with cancer vaccines. Definition of disease progression in context of clinical rather image-specific criteria and interpretation of efficacy in relation to delayed effect of cancer vaccines should be taken into account in the design of future of immunotherapy trials.
引用
收藏
页码：3236 / 3240
页数：5
相关论文
共 50 条
  • [31] What do we know? What do we need to know?
    Milena J. Henzlova
    W. Lane Duvall
    Journal of Nuclear Cardiology, 2017, 24 : 252 - 254
  • [32] What do we know? What do we need to know?
    Henzlova, Milena J.
    Duvall, W. Lane
    JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (01) : 252 - 254
  • [33] Cancer Clinical Trials-Do We Need a New Algorithm in the Age of Stratified Medicine?
    Doroshow, James H.
    Sleijfer, Stefan
    Stupp, Roger
    Anderson, Kenneth
    ONCOLOGIST, 2013, 18 (06): : 651 - 652
  • [34] Dendritic cell-based therapeutic cancer vaccines: what we have and what we need
    Kalinski, Pawel
    Urban, Julie
    Narang, Rahul
    Berk, Erik
    Wieckowski, Ewa
    Muthuswamy, Ravikumar
    FUTURE ONCOLOGY, 2009, 5 (03) : 379 - 390
  • [35] Clinical Potencies of Glucocorticoids: What do we Really Measure?
    Dubois, Emile F. L.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2005, 1 (01) : 103 - 108
  • [36] CLINICAL THYROIDOLOGY 1992 - WHAT DO WE REALLY NEED
    RICCABONA, G
    DEGROOT, LJ
    DELANGE, F
    DUNN, JT
    GALVAN, G
    PIYASENA, RD
    REINWEIN, D
    ROHER, H
    ROSLER, H
    SCHLUMBERGER, M
    STANBURY, JB
    VITTI, P
    WILLIAMS, D
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1993, 16 (04) : 297 - 302
  • [37] Which trials do we need?
    Leibovici, Leonard
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (07) : 843 - 844
  • [38] Client satisfaction and clinical outcomes do we need to measure both?
    Eisen, SV
    BEHAVIORAL HEALTHCARE TOMORROW, 1996, 5 (04): : 71 - 73
  • [39] The safety of adjuvants in influenza vaccines during pregnancy: what do we know and why do we need them?
    Jamieson, Denise J.
    Rasmussen, Sonja A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 207 (03) : 145 - 146
  • [40] TEACHER CERTIFICATION TESTS - DO THEY REALLY MEASURE WHAT WE NEED TO KNOW
    MADAUS, GF
    PULLIN, D
    PHI DELTA KAPPAN, 1987, 69 (01) : 31 - 38
12345